Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Gross Profit Growth Accelerating
Trending higher, above historical average, structural decline.
Left:
||||
Year-over-year gross profit growth rate
Latest
-3.82%
↑ 98% above average
Average (9y)
-172.53%
Historical baseline
Range
High:1095.45%
Low:-2079.72%
CAGR
-29.9%
Structural decline
| Period | Value |
|---|---|
| 2024 | -3.82% |
| 2023 | -82.28% |
| 2022 | -40.20% |
| 2021 | 110.87% |
| 2020 | -710.94% |
| 2019 | 120.25% |
| 2018 | -41.07% |
| 2017 | -2079.72% |
| 2016 | 1095.45% |
| 2015 | -93.87% |